Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw unusually large options trading on Wednesday. Investors purchased 1,885 put options on the stock. This represents an increase of 1,101% compared to the average daily volume of 157 put options.

Evelo Biosciences Stock Performance

NASDAQ EVLO opened at $0.00 on Thursday. The stock has a market cap of $7,592.00, a price-to-earnings ratio of 0.00 and a beta of 1.29. The business has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.03. Evelo Biosciences has a 52-week low of $0.00 and a 52-week high of $0.50.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.